Additional Investment from Sichuan Hebang Biotechnology
Filed with ASX · · 2 pages · English
▪ Avenira Limited (ASX: AEV) (“Avenira” or “the Company”) has secured an additional investment from its largest shareholder, Hebang Biotechnology (Hong Kong) Investment Limited (“Hebang”), being a wholly-owned subsidiary of Sichuan Hebang Biotechnology Corporation Limited (SHSE: 603077) (“Sichuan Hebang”). ▪ The Strategic Investment comprises a placement of A$8,785,842 at an issue price of A$0.007
Story so far
Earlier from Avenira
- Quarterly Activities/Appendix 5B Cash Flow Report
- Board and Management Changes
- Avenira Limited - Hebang Unsecured Loan Facility - 2nd Drawdown
- Wonarah Mine Management Plan Approved by the NT Government
- Investment from Sichuan Hebang Biotechnology
Later from Avenira
- Unsecured Loan Facility from MLHK Vehicle 1 Limited
- Change to Financial Year
- Proposed issue of securities - AEV
- Renounceable Rights Issue to Raise up to $49 Million
- Renounceable Entitlement Offer Prospectus
Follow Avenira into a list and get an email when it puts out news.
Follow Avenira